학술논문

A0752 - Identification of resistance mechanisms to evaluate therapeutic options for refractory yolk-sac tumors using multikinase inhibitors or antibody (CLDN6)-/ nanobody (CXCR4)-drug-conjugates.
Document Type
Article
Source
European Urology. Feb2023:Supplement 1, Vol. 83, pS1063-S1064. 2p.
Subject
*CXCR4 receptors
*IMMUNOGLOBULINS
*TUMORS
Language
ISSN
0302-2838